1. 1) Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA, 323, 1945–1960 (2020).
2. 2) Albanesi C, Madonna S, Gisondi P, Girolomoni G. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front. Immunol., 9, 1549 (2018).
3. 3) Polese B, Zhang H, Thurairajah B, King IK. Innate lymphocytes in psoriasis. Front. Immunol., 11, 242 (2020).
4. 4) Bos JD, Hagenaars C, Das PK, Krieg SR, Voorn WJ, Kapsenberg ML. Predominance of “memory” T cells (CD4+, CDw29+) over “naïve” T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch. Dermatol. Res., 281, 24–30 (1989).
5. 5) De Panfilis G, Manara GC, Ferrari C, Torresani C, Zucchi A, Devoto RM. Further characterization of the “incipient lesion of chronic stationary type psoriasis vulgaris in exacerbation”. The CD4-positive lymphocytes are the prominent cell population infiltrating the dermis. Acta Derm. Venereol. Suppl. (Stockh.), 146, 26–30 (1989).